ArticleCancers2022

Peripheral Blood Biomarkers Predictive of Efficacy Outcome and Immune-Related Adverse Events in Advanced Gastrointestinal Cancers Treated with Checkpoint Inhibitors.

Zhening Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.